"Eli Lilly is in talks to acquire AtaiBeckley, one of the leading developers of next-generation psychedelic therapies."
ZeroHedge Reads
Alt-Market
AntiWar.com
Bitcoin Magazine
Bombthrower
Eli Lilly agrees to $3.8B psychedelic buy
Lilly to buy AtaiBeckley for $2.8B, further validating psychedelics
Lilly bets $2.8B upfront on psychedelics in deal to buy AtaiBeckley
Lilly enters psychedelic drug race with up to $3.8 billion AtaiBeckley deal
Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion as experimental treatments gain traction
Eli Lilly to acquire psychedelics-focused biotech AtaiBeckley
Weight-loss drugmaker Lilly nears $1.97 bn AtaiBeckley's acquisition: Report
OpenAi and Anthropic are about to go nuclear against each other, while China watches from the sidelines knowing it will soon…
The AtaiBeckley acquisition would be the largest psychedelic deal to date.
How high can we push valuations before something snaps violently?
AI is likewise becoming one big short correlation trade...
...markets reconcile ambition with economic scarcity...
The latest in a prolific streak of buyouts by Lilly is the strongest sign yet that large pharmaceutical companies may finally be…
